lecture 3 Flashcards

1
Q

What are the two most common types of venous thromboembolism (VTE)?

A

Deep vein thrombosis (DVT) and pulmonary embolism (PE).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does a pulmonary embolism (PE) occur?

A

A blood clot breaks loose (embolises) and travels to the pulmonary circulation, blocking blood flow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the components of Virchow’s Triad, summarising VTE pathophysiology?

A

Venous stasis, endothelial injury, and hypercoagulability.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the long-term complications of VTE?

A

Post-thrombotic syndrome (PTS) and chronic thromboembolic pulmonary hypertension (CTEPH).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Name three common risk factors for VTE.

A

Obesity, hospitalisation, and surgery with general anaesthesia lasting >90 minutes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does increasing age affect VTE incidence?

A

The incidence rises significantly, reaching ~1/100 in patients over 80 years old.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the classic signs and symptoms of DVT?

A

Leg pain, swelling, tenderness, discolouration, and pitting oedema.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the common symptoms of a pulmonary embolism?

A

Shortness of breath, chest pain, haemoptysis, tachycardia, and hypotension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some atypical presentations of VTE?

A

Bilateral leg swelling, asymptomatic clots (e.g., found on cancer staging CT), or VTE at unusual sites (e.g., cerebral veins).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the key aims of clinical and laboratory assessment in suspected VTE?

A

To confirm the presence of VTE, identify the underlying cause, assess contraindications to anticoagulation, and address other clinical considerations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which clinical scoring system is commonly used to assess DVT risk?

A

The two-level DVT Wells score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the significance of a Wells score ≥2 for DVT?

A

It indicates that DVT is likely, warranting further investigation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the initial confirmatory test for DVT diagnosis?

A

Proximal leg vein ultrasound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When is a D-dimer test useful in suspected DVT?

A

To rule out DVT in patients with a low Wells score and no other risks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are potential causes of elevated D-dimer levels aside from VTE?

A

Infection, inflammation, malignancy, pregnancy, and recent surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What imaging is used to confirm pulmonary embolism?

A

CT pulmonary angiography (CTPA) or ventilation-perfusion (V/Q) scan.

17
Q

How does heparin work as an anticoagulant?

A

It enhances antithrombin’s inhibition of clotting factors, particularly factor IIa (thrombin) and Xa.

18
Q

What is the mechanism of action of warfarin?

A

It inhibits vitamin K epoxide reductase, reducing the synthesis of clotting factors II, VII, IX, and X.

19
Q

Name two advantages of direct oral anticoagulants (DOACs) over warfarin.

A

Fixed dosing with no routine monitoring and lower risk of intracranial bleeding.

20
Q

Why is low molecular weight heparin (LMWH) preferred during pregnancy?

A

It does not cross the placenta and is safer for the fetus.

21
Q

How is warfarin’s anticoagulant effect monitored?

A

Using the international normalised ratio (INR).

22
Q

What is the standard duration of anticoagulation for provoked VTE?

A

Three months.

23
Q

When might indefinite anticoagulation be considered for VTE?

A

For unprovoked VTE or when persistent significant risk factors (e.g., cancer) are present

24
Q

What anticoagulants are first-line for VTE treatment?

A

Direct oral anticoagulants (DOACs), such as rivaroxaban or apixaban.

25
Q

Why is long-term anticoagulation not always initiated immediately after acute VTE?

A

The decision depends on the balance of recurrence risk off anticoagulation versus bleeding risk on anticoagulation.

26
Q

What is the first step in reducing the risk of hospital-acquired VTE?

A

Conducting a VTE risk assessment for all admitted patients.

27
Q

When should LMWH thromboprophylaxis be started for hospitalised patients?

A

Within 14 hours of admission if the VTE risk outweighs the bleeding risk

28
Q

Name two mechanical methods to prevent hospital-acquired VTE

A

Anti-embolic stockings and intermittent pneumatic compression devices.

29
Q

What lifestyle measures can help reduce VTE risk during hospitalisation?

A

Encouraging hydration and early mobilisation.

30
Q

What is the role of patient education in preventing VTE after hospital discharge?

A

Patients should be informed about ongoing VTE risk and provided with instructions on thromboprophylaxis if needed.